Acro Biomedical (ACBM) Shares Outstanding (Weighted Average) (2015 - 2025)

Acro Biomedical's Shares Outstanding (Weighted Average) history runs 11 years deep, the most recent figure standing at $60.0 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $60.0 million; the TTM figure through Dec 2025 stood at $60.0 million (changed 0.0% YoY), while the FY2025 annual figure was $60.0 million, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) was $60.0 million for Q4 2025 at Acro Biomedical, roughly flat from $60.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $60.0 million in Q4 2021 to a low of $47.8 million in Q1 2021.
• Historically, Shares Outstanding (Weighted Average) has averaged $59.3 million across 5 years, with a median of $60.0 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Weighted Average) changed 0.0% in 2021, then increased 25.72% in 2022.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $60.0 million in 2021, then changed by 0.0% to $60.0 million in 2022, then changed by 0.0% to $60.0 million in 2023, then changed by 0.0% to $60.0 million in 2024, then changed by 0.0% to $60.0 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $60.0 million (Q4 2025), $60.0 million (Q3 2025), and $60.0 million (Q2 2025), per Business Quant data.